emerging-tech-investing Integrated Quantum Technologies Unveils AIQu VEIL, a Breakthrough Quantum-Resilient AI Infrastructure Platform Redefining Enterprise AI
emerging-tech-investing Integrated Quantum Technologies Appoints Former Equifax Leader Jeremy Samuelson as EVP, Artificial Intelligence and Innovation
emerging-tech-investing Integrated Quantum Technologies Unveils Corporate Website and Investor Presentation, Advancing Its Vision for Post-Quantum Enterprise AI Infrastructure
emerging-tech-investing Integrated Quantum Technologies Files Provisional Patent for Post-Quantum AI Infrastructure Platform, AIQu
emerging-tech-investing Integrated Quantum Technologies Announces Appointment of Mickey Goldstein as Chief Financial Officer
emerging-tech-investing Integrated Cyber Solutions Inc. Rebrands as Integrated Quantum Technologies Inc. , Expanding Mission to Secure the Future of AI
emerging-tech-investing Integrated Cyber Solutions Announces Closing of Over-Subscribed Non-Brokered Private Placement of Common Shares
emerging-tech-investing Integrated Cyber Solutions Announces Non-Brokered Private Placement of Common Shares
emerging-tech-investing Integrated Cyber Solutions Initiates Patent Process for Quantum-Resilient AI Deployment & Data Securitization Technology
emerging-tech-investing Integrated Cyber Solutions Names Cybersecurity Leader Richard Noonan to Cyber Future Advisory Board and Announces Grant of Compensation Securities
emerging-tech-investing Integrated Cyber Solutions Appoints Veteran Data & AI Scientist Jeremy J. Samuelson to Cyber Future Advisory Board
artificial-intelligence-investin Integrated Cyber Solutions Corrects Statement in Previous Release Issued on April 2, 2024
artificial-intelligence-investin Integrated Cyber Solutions Unveils Joint Venture Partnership with Hospitality Company in the Middle East
Jura Announces Dismissal in Full of PEL's Appeal against certain reliefs granted in the Settlement Agreement Arbitral Award
American Pacific Mails Meeting Materials for Annual General and Special Meeting in Connection with Previously Announced Plan of Arrangement with ICG Silver & Gold Ltd.
Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment
